Article
Variability in DNA methylation defines novel epigenetic subgroups of DLBCL associated with different clinical outcomes.
Blood - 13 Mar 2014
Chambwe Nyasha, Kormaksson Matthias, Geng Huimin, De Subhajyoti, Michor Franziska, Johnson Nathalie A, Morin Ryan D, Scott David W, Godley Lucy A, Gascoyne Randy D, Melnick Ari, Campagne Fabien, Shaknovich Rita
Abstract excerpt
Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive form of non-Hodgkin lymphoma with variable biology and clinical behavior. The current classification does not fully explain the biological and clinical heterogeneity of DLBCLs. In this study, we carried out genomewide DNA methylation profiling of 140 DLBCL samples and 10 normal germinal center B cells using the HpaII tiny fragment enrichment by...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
